Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European Liver and Intestine Transplantation Association and European Liver Transplant Registry
Jazyk angličtina Země Švýcarsko Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
Astellas - International
Novartis - International
Institut Georges Lopez - International
Sandoz - International
Paul Brousse Hospital - International
PubMed
32609908
PubMed Central
PMC7361228
DOI
10.1111/tri.13680
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, SARS-CoV-2, liver recipient, liver transplantation, mortality, survey,
- MeSH
- časná diagnóza MeSH
- COVID-19 diagnóza epidemiologie MeSH
- dárci tkání statistika a číselné údaje MeSH
- imunokompromitovaný pacient MeSH
- incidence MeSH
- komorbidita MeSH
- lidé MeSH
- nemoci jater epidemiologie chirurgie MeSH
- pandemie * MeSH
- plošný screening MeSH
- pooperační komplikace epidemiologie MeSH
- příjemce transplantátu statistika a číselné údaje MeSH
- průzkumy zdravotní péče MeSH
- registrace MeSH
- riziko MeSH
- SARS-CoV-2 * MeSH
- testování na COVID-19 MeSH
- transplantace jater statistika a číselné údaje MeSH
- výběr dárců normy MeSH
- využití postupů a technik MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa epidemiologie MeSH
There are scarce data on the impact of COVID-19 pandemic on liver transplantation (LT) in Europe. The aim of this study was to obtain a preliminary data on incidence, management, and outcome of COVID-19 in liver transplant recipients and candidates in Europe. An Internet-based survey was sent to the centers affiliated with European Liver Transplant Registry (ELTR). One hundred nine out of 149 (73%) of ELTR centers located in 28 European countries (93%) responded. Ninety-four (86%) of the centers tested all donors, and 75 (69%) centers tested all LT recipients for SARS-CoV-2. Seventy-three (67%) centers selected recipients for LT in the COVID-19 pandemic, whereas 33% did not. Eighty-eight centers reported COVID-19 infection in 57 LT candidates and in 272 LT recipients. Overall crude incidence of COVID-19 among LT candidates and recipients was estimated 1.05% (range 0.5-20%) and 0.34% (range 0.1-4.8%), respectively, and it was significantly higher among candidates (P < 0.001). Crude rate of death was 18% (10/57) among candidates and 15% (36/244) among recipients. This first large-scale European snapshot study clearly shows that both LT candidates and recipients are at a high risk for COVID-19. These results plead for an early and pro-active screening of COVID-19 symptoms in these populations.
Department of Clinical Medicine and Surgery Federico 2 University Naples Italy
Department of General Transplant and Liver Surgery Medical University of Warsaw Warsaw Poland
Division of Abdominal Surgery Department of Surgery Geneva University Hospitals Geneva Switzerland
Division of Hepatology and Gastroenterology ASST Grande Ospedale Metropolitano Niguarda Milan Italy
Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK
Zobrazit více v PubMed
Lescure FX, Bouadma L, Nguyen D, PubMed PMC
Zhou F, Yu T, Du R, PubMed PMC
http://www.euro.who.int/en/health‐topics/health‐emergencies/coronavirus‐covid‐19/news/news/2020/3/who‐announces‐covid‐19‐outbreak‐a‐pandemic.
Akalin E, Azzi Y, Bartash R, PubMed PMC
Fernández‐Ruiz M, Andrés A, Loinaz C, PubMed PMC
Aigner C, Dittmer U, Kamler M, Collaud S, Taube C. COVID‐19 in a lung transplant recipient. J Heart Lung Transplant 2020; 39: 610. PubMed PMC
Mehta P, McAuley DF, Brown M, PubMed PMC
Guillen E, Pineiro GJ, Revuelta I, PubMed PMC
Bhoori S, Rossi RE, Citterio D, Mazzaferro V. long‐term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy. Lancet Gastroenterol Hepatol 2020; 5: 532. PubMed PMC
www.gisaid.org.
worldpopulationreview.com.
https://edu.esottransplantlive.org.
Domínguez‐Gil B, Coll E, Fernández‐Ruiz M, PubMed DOI PMC
Angelico R, Trapani S, Manzia TM, Lombardini L, Tisone G, Cardillo M. The COVID‐19 outbreak in Italy: initial implications for organ transplantation programs. Am J Transplant 2020; 20: 1780. PubMed PMC
Adam R, Karam V, Cailliez V, PubMed
Fix OK, Hameed B, Fontana RJ, PubMed DOI PMC
Ritschl PV, Nevermann N, Wiering L, PubMed PMC
Maggi U, De Carlis L, Yiu D, PubMed DOI PMC
Lauterio A, De Carlis R, Belli L, Fumagalli R, De Carlis L. How to guarantee liver transplantation in the north of Italy during the COVID‐19 pandemic. A sound transplant protection strategy. Transpl Int 2020). 33, 969. 10.1111/tri.13633. PubMed DOI